Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene Forms European Institute Headed by U Torino Researcher Alberto Bardelli

NEW YORK (GenomeWeb) – Trovagene today announced that it is establishing a European subsidiary, Trovagene Research Institute, charged with expanding the capabilities and adoption of the company's Precision Cancer Monitoring platform.

Alberto Bardelli, a University of Torino liquid biopsy researcher, will serve as scientific chair of TRI, Trovagene said. Bardelli has also been a member of the company's scientific advisory board for the past year.

Bardelli and colleagues recently published a study in Nature Medicine, showing that they were able to detect cancer mutations in blood that reflected clonal evolution and the development of resistance to anti-EGFR therapies in colorectal cancer patients.

Concurrent with the establishment of TRI, Trovagene said it has entered into a collaboration with the Department of Oncology at the University of Torino, which will focus specifically on advancing urine as a sample source for the detection and monitoring of cancer mutations.

"The University is looking forward to working with TRI to make Trovagene's novel liquid biopsy platform available to clinicians and patients in Europe," Giorgio Scagliotti, director of the Department of Oncology at the University of Torino, said in a statement.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.